Despite these results, no S100-β peptide epitopes targeted by CD8+ cytotoxic T lymphocytes (CTLs) in T1D patients have been identified, nor has their potential effectiveness in preventing diabetes development been reported. The gene discussed is S100B; the disease is diabetes mellitus.